Form 8-K · Current report
Constellation Brands 8-K, filed Sep 8, 2026
- Filed
- CIK
- 0000016918
- Accession no.
- 0000016918-26-000034
Summary
Constellation Brands gave notice for the full redemption prior to maturity of all $600.0 million outstanding aggregate principal amount of its 4.350% Senior Notes due 2027, to be effected September 18, 2026. The company said it intends to fund the redemption with commercial paper borrowings and/or cash on hand, and that the cash redemption price will be calculated under the formula in the supplemental indenture.
Key points
- As of September 8, 2026, $600.0 million in aggregate principal amount of the 4.350% Senior Notes due 2027 (CUSIP 21036P BK3) was outstanding.
- The redemption is to be effected on September 18, 2026.
- The redemption price will be calculated pursuant to the formula in the supplemental indenture governing the notes, and terms are described in the notice distributed to holders by the trustee.
- Constellation Brands disclosed the redemption notice under Item 7.01 Regulation FD Disclosure in a Form 8-K.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 7.01 Regulation FD Disclosure. On September 8, 2026, Constellation Brands, Inc. (the “Company”) issued a news release announcing that it has given notice for full redemption prior to maturity of all of its outstanding 4.350% Senior Notes due 2027. The Company intends to use commercial paper borrowings and/or cash on hand to fund the redemption. A copy of the news release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in the news release attached as Exhibit 99.1 is incorporated by reference into this Item 7.01 in satisfaction of the public disclosure requirements of Regulation FD. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.